$IVA News

Inventiva Enters Comprehensive Refinancing Agreements, Comprising Repayment Of The Existing EIB Loan And Partial Warrant Buyback Of Those Issued The EIB; Shares Resume Rrading On Euronext Paris

Inventiva Halts Paris Trading Ahead of Planned Financing Announcement, Shares Expected to Resume Trading Later Tuesday

Inventiva's Speculative Upside Through MASH Is Promising

Inventiva Recruits Axel-Sven Malkomes As New CFO

Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F

Inventiva SA (IVA) (Q4 2025) Earnings Call Highlights: Strategic Milestones and Financial ...

Inventiva Q4 Earnings Call Highlights

Inventiva reports 2025 full year results and provides a business update

Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate

Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results

Truist Securities Initiates Coverage On Inventiva with Buy Rating, Announces Price Target of $13

Assessing Inventiva (ENXTPA:IVA) Valuation After A Strong 12‑Month Rebound In Shareholder Returns

Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect?

Inventiva to Participate in Four Upcoming March Investor Conferences

Inventiva reports preliminary 2025¹ fiscal year financial results

Inventiva Reports Preliminary 2025 Financial Results With €99.3M Cash, €131.6M Short-Term Deposits And €4.5M Revenues, Runway Into Q1 2027

Inventiva Reports Preliminary 2025 Financial Results With €99.3M Cash, €131.6M Short-Term Deposits And €4.5M Revenues, Runway Into Q1 2027

Inventiva CEO: Phase 3 Lanifibranor MASH Trial Fully Enrolled, Top-Line Data Due in H2

Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Assessing Inventiva (ENXTPA:IVA) Valuation After A 126% One Year Total Return